Viewing Study NCT00089193


Ignite Creation Date: 2025-12-25 @ 1:15 AM
Ignite Modification Date: 2026-04-10 @ 10:03 AM
Study NCT ID: NCT00089193
Status: COMPLETED
Last Update Posted: 2014-12-23
First Post: 2004-08-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
Sponsor: Craig L Slingluff, Jr
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module